Covid-19 roundup: Paul Hudson says US will have first dibs on Sanofi vaccine; Gilead selects 5 generic manufacturing partners for remdesivir
If Sanofi can successfully deliver a Covid-19 vaccine, the US will get first access to it, CEO Paul Hudson told Bloomberg News.
That’s because the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
